COVID‐19 related immune hemolysis and thrombocytopenia
Kamal Kant Sahu, Azra Borogovac, Jan Černý
Abstract
The current pandemic due to coronavirus disease 2019 (COVID-19) has posed an unprecedented challenge for the medical communities, various countries worldwide, and their citizens. Severe acute respiratory syndrome coronavirus 2 has been studied for its various pathophysiological pathways and mechanisms through which it causes COVID-19. In this study, we discussed the immunological impact of COVID-19 on the hematological system, platelets, and red blood cells.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)HemolysisPandemicVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusImmunologyMedicineImmune systemInfectious disease (medical specialty)PathophysiologyDiseasePathologyOutbreakPlatelet Disorders and TreatmentsCOVID-19 Clinical Research StudiesBlood properties and coagulation